Buhlmann Diagnostics Corp Archives - Page 3 of 3 - Buhlmann Diagnostics Corp

Category: Buhlmann Diagnostics Corp

New Health Canada License for BÜHLMANN fCAL® turbo

BÜHLMANN fCAL® turbo Speed, Quality and Flexibility in Calprotectin Quantification BUHLMANN Diagnostics Corp (BDC), BÜHLMANN Laboratories AG’s North American affiliate is proud to announce that its innovative product, BÜHLMANN fCAL® turbo, has received a Medical Device License from Health Canada and is now commercially available in Canada.  The device was approved as a Class 2
Continue Reading

Connect with BUHLMANN Diagnostics Corp (BDC) at DDW 2016

When: May 21-24, 2016 Where: San Diego, California Booth: #4155 More Information: Digestive Disease Week (DDW) 2016
Continue Reading

Connect with BUHLMANN Diagnostics Corp at CDDW 2016

When: February 26 - 29, 2016 Where: Montreal, Quebec, Canada - Fairmont Queen Elizabeth Hotel' Booth: #1050 More Information Canadian Digestive Diseases Week
Continue Reading

Market Launch Of CALEX Device

  BÜHLMANN announces the launch and introduction of the brand new stool extraction device CALEX® Cap. The features of the CALEX® extraction tool are unique in the market: Ease of use for laboratory personnel and subjects Application as primary tube for all ELISA robots on the market An optimized sample dilution for maximum efficiency in

Continue Reading